In a clinical trial of 2103 subjects treated with Nasonex, 26 reported headaches. In a control group of 1671 subjects given a placebo, 22 reported headaches. Denoting the proportion of headaches in the treatment group by pt and denoting the proportion of headaches in the control (placebo) group by pc, the relative risk is pt/pc. The relative risk is a measure of the strength of the effect of the Nasonex treatment. Another such measure is the odds ratio, which is the ratio of the odds in favor of a headache for the treatment group to the odds in favor of a headache for the control (placebo) group, found by evaluating the following:

The relative risk and odds ratios are commonly used in medicine and epidemiological studies. Find the relative risk and odds ratio for the headache data. What do the results suggest about the risk of a headache from the Nasonex treatment?

Transcribed Image Text:

2 Pe